Axogen (STU:LT3) General and Admin. Expense: €41.2 Mil (TTM As of Mar. 2026)


STU:LT3 Axogen Inc STU:LT3
70 GF Score
Price €35.45
GF Value €13.23
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Axogen General and Admin. Expense?

Axogen STU:LT3 -7.00% 70 General and Admin. Expense is €41.2 Mil as of Mar. 2026. GuruFocus rates STU:LT3 with a GF Score™ of 70/100 and a GF Value™ of €13.23 (Significantly Overvalued). The stock has 2 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Axogen's General and Admin. Expense for the three months ended in Mar. 2026 was €11.1 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €41.2 Mil.

Axogen General and Admin. Expense Related Terms

Axogen General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Axogen's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Axogen General and Admin. Expense Chart

Axogen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.62 38.62 35.22 37.28 38.07

Axogen Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.75 8.40 9.23 12.46 11.13
STU:LT3
70GF Score
Axogen Inc STU:LT3
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Axogen General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €41.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of €41.2 Mil mean?
Axogen (STU:LT3) has a General and Admin. Expense of €41.2 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Axogen and its competitors.
Is Axogen's General and Admin. Expense too high?
Axogen's current General and Admin. Expense is €41.2 Mil. Overall, Axogen has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Axogen's General and Admin. Expense compare to TMDX and BFLY?
Axogen's General and Admin. Expense of €41.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Medical Devices & Instruments company?
A good General and Admin. Expense depends on the Medical Devices & Instruments industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Axogen and its competitors. Axogen's current General and Admin. Expense is €41.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Axogen stock overvalued right now?
Based on GuruFocus' analysis, Axogen (STU:LT3) is currently considered Significantly Overvalued. The stock's GF Value™ is €13.23, compared to a current price of €35.45 — trading 168% above its estimated fair value. The current General and Admin. Expense is €41.2 Mil. Axogen's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Axogen (STU:LT3), the current General and Admin. Expense is €41.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Axogen (STU:LT3) Overvalued in 2026?

Based on GuruFocus' analysis, Axogen stock appears to be overvalued. The current stock price of €35.45 is trading 168% above its estimated GF Value™ of €13.23. GuruFocus considers Axogen to be Significantly Overvalued.

Key valuation signals for STU:LT3:

  • General and Admin. Expense: €41.2 Mil
  • GF Value™: €13.23 vs. price of €35.45 (168% above fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the STU:LT3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Axogen Business Description

Other Exchanges AXGN:USA0HKD:UK
Address 13631 Progress Boulevard, Suite 400, Alachua, FL, USA, 32615
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
70GF Score

Get the complete analysis for STU:LT3

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€35.45
Price
€13.23
GF Value